Company / Profit Margin
GYRE THERAPEUTICS, INC. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
8.5%
FY2025
5-year range
-1198.3% / 16.9%
FY2021-FY2025
Trend
-49.9%
vs FY2024
Sector context
#42 of 145
Health Care
What the data says
At 8.5%, GYRE THERAPEUTICS, INC.'s profit margin ranks #42 of 145 in the Health Care sector. Profit Margin has fluctuated over the past 7 years, ranging from -2118.0% in FY2018 to 16.9% in FY2024.
Based on SEC 10-K filings.
8.5% in FY2025 with a 5-year CAGR of +271.9%.
Improved from 4.2% to 8.5% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +4.3pp
- 5-Year Change
- +271.9pp
- 10-Year Change
- -
Sector benchmark
#42 of 145 in Health CareTop 29% of 145This company 8.5% Sector average -792.7%
▼
+101.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 49.9% year-over-year.
- Currently 801.2pp above the Health Care sector average.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.5% | -49.9% |
| FY2024 | 16.9% | +300.9% |
| FY2023 | 4.2% | +0.0% |
| FY2022 | 4.2% | +100.4% |
| FY2021 | -1198.3% | -354.9% |
| FY2020 | -263.4% | - |
| FY2019 | - | - |
| FY2018 | -2118.0% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026